- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/542 - ImmunoassayBiospecific binding assayMaterials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
Patent holdings for IPC class G01N 33/542
Total number of patents in this class: 1340
10-year publication summary
|
92
|
96
|
101
|
98
|
79
|
81
|
79
|
76
|
80
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Promega Corporation | 582 |
30 |
| The Regents of the University of California | 20427 |
28 |
| Centre National de La Recherche Scientifique | 10820 |
27 |
| Ventana Medical Systems, Inc. | 1053 |
21 |
| Bio-Rad Laboratories, Inc. | 1612 |
16 |
| Biomadison, Inc. | 51 |
15 |
| Board of Regents, The University of Texas System | 6020 |
14 |
| Cisbio Bioassays | 66 |
14 |
| Technische Universiteit Eindhoven | 377 |
14 |
| Becton, Dickinson and Company | 7504 |
12 |
| Massachusetts Institute of Technology | 10189 |
12 |
| Procisedx Inc. | 22 |
12 |
| The Board of Trustees of the Leland Stanford Junior University | 6589 |
11 |
| F. Hoffmann-La Roche AG | 7879 |
10 |
| President and Fellows of Harvard College | 6058 |
9 |
| Beckman Coulter, Inc. | 1302 |
9 |
| Urteste S.A. | 27 |
9 |
| The Johns Hopkins University | 5782 |
8 |
| The General Hospital Corporation | 4802 |
8 |
| Pacific Biosciences of California, Inc. | 749 |
8 |
| Other owners | 1053 |